» Articles » PMID: 20179792

The Diagnosis and Management of Hereditary Haemochromatosis

Overview
Specialty Biochemistry
Date 2010 Feb 25
PMID 20179792
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary haemochromatosis (HH) is a common genetic disorder of iron metabolism in individuals of Northern European ancestry which leads to inappropriate iron absorption from the intestine and iron overload in susceptible individuals. Iron overload is suggested by elevations in serum ferritin and transferrin saturation. The majority of patients with clinically significant iron overload are homozygous for the C282Y mutation of the HFE gene, however only a minority of C282Y homozygotes fully express the disease clinically. Those with a high serum ferritin (>1000 microg/L) and additional hepatic insults from cofactors are more likely to develop cirrhosis and its complications. The mainstay of treatment is venesection. Those without cirrhosis who undergo appropriate venesection have a normal life expectancy. Family screening is recommended for all first degree relatives of an individual with the disease.

Citing Articles

The Iron Enigma: Expounding Iron Deficiency in a Pregnant Woman With Hemochromatosis and Celiac Disease.

Idrees Z, Khan H, Akhtar M, Khan U Cureus. 2024; 16(10):e71926.

PMID: 39564070 PMC: 11576064. DOI: 10.7759/cureus.71926.


The IRONy in Athletic Performance.

Kardasis W, Naquin E, Garg R, Arun T, Gopianand J, Karmakar E Nutrients. 2023; 15(23).

PMID: 38068803 PMC: 10708480. DOI: 10.3390/nu15234945.


Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis.

Jarvik G, Wang X, Fontanillas P, Kim E, Chanprasert S, Gordon A HGG Adv. 2022; 1(1):100010.

PMID: 35047832 PMC: 8756515. DOI: 10.1016/j.xhgg.2020.100010.


Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke G, Kell D PLoS One. 2014; 9(1):e85271.

PMID: 24416376 PMC: 3887013. DOI: 10.1371/journal.pone.0085271.


Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations.

Zamani F, Bagheri Z, Bayat M, Fereshtehnejad S, Basi A, Najmabadi H Med Sci Monit. 2012; 18(10):CR622-9.

PMID: 23018356 PMC: 3560564. DOI: 10.12659/msm.883489.


References
1.
Pietrangelo A . Non-HFE hemochromatosis. Semin Liver Dis. 2005; 25(4):450-60. DOI: 10.1055/s-2005-923316. View

2.
Beutler E, Felitti V, Gelbart T, Ho N . The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000; 133(5):329-37. DOI: 10.7326/0003-4819-133-5-200009050-00008. View

3.
Power T, Adams P . Psychosocial impact of C282Y mutation testing for hemochromatosis. Genet Test. 2001; 5(2):107-10. DOI: 10.1089/109065701753145556. View

4.
Powell E, Ali A, Clouston A, Dixon J, Lincoln D, Purdie D . Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology. 2005; 129(6):1937-43. DOI: 10.1053/j.gastro.2005.09.015. View

5.
Bacon B . Hemochromatosis: diagnosis and management. Gastroenterology. 2001; 120(3):718-25. DOI: 10.1053/gast.2001.21913. View